2014
DOI: 10.1016/j.jalz.2014.05.1261
|View full text |Cite
|
Sign up to set email alerts
|

P3‐171: Characteristics of Early Onset Dementia in a Hospital Setting From Romania

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Pharmacological therapies may be more beneficial for AD patients if they target mechanisms that become abnormal at the very beginning of the course of the disease when symptoms are minimal. A great challenge would be to identify standard practical biomarkers that can detect these early changes—biomarkers that could become available for current clinical practice and wider use [ 43 , 44 , 48 , 49 , 50 , 51 , 52 , 53 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pharmacological therapies may be more beneficial for AD patients if they target mechanisms that become abnormal at the very beginning of the course of the disease when symptoms are minimal. A great challenge would be to identify standard practical biomarkers that can detect these early changes—biomarkers that could become available for current clinical practice and wider use [ 43 , 44 , 48 , 49 , 50 , 51 , 52 , 53 ].…”
Section: Discussionmentioning
confidence: 99%
“…Indirect scientific evidence for this correlation was tested in different study designs when investigating the effects of vitamin D supplementation on cognitive outcomes in elderly individuals. There is no clear notion of when vitamin D (natural or administered as a supplement) is most effective in the pathogenesis of cognitive decline, particularly in AD; the pre-existing neurological insult could have been the reason for the failure of introducing such therapy too late or in insufficient doses [ 32 , 51 , 54 , 59 ]. Overall, conflicting evidence is provided by studies, which found that vitamin D supplementation neither improved cognitive outcomes nor reduced the risk of dementia or MCI compared to the controls.…”
Section: Discussionmentioning
confidence: 99%